6. Brugg B., Dubreuil Y. L., Huber G., Wollman E. E., Delhaye-Bouchaud N. and Mariani J. (1995) Inflammatory
processes induce â-amyloid precursor protein changes in mouse brain. Proc. natn. Acad. Sci. U.S.A. 92, 3032–3035.
7. Drapier J.-C. and Hibbs J. B. Jr (1988) DiVerentiation of mouse macrophages to express nonspecific cytotoxicity for
tumor cells results in l-arginine-dependent inhibition of mitochondrial iron–sulfur enzymes in the macrophage eVector
cells. J. Immun. 140, 2829–2838.
8. Finsen B. R., Jorgensen M. B. and Zimmer J. (1993) Microglia MHC antigen expression after ischemic and kainic acid
lesions of the adult rat hippocampus. Glia 7, 41–49.
9. Flaris N. A., Densmore T. L., Molleston M. C. and Hickey W. F. (1993) Characterization of microglia and
macrophages in the central nervous system of rats: definition of the diVerential expression of molecules using standard
and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia 7, 34–40.
10. Foley P., Bradford H. F., Dochart M., Fillet H., Luine V. N., McEwen B., Buch G., Winblad B. and Hardy J. (1988)
Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer disease.
J. Neurol. 235, 466–471.
11. Fonnum F. (1969) Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem. J. 115, 465–472.
12. Frederickson R. C. A. and Brunden K. R. (1994) New opportunities in AD research—roles of immunoinflammatory
responses and glia. Alz. Dis. Assoc. Disord. 8, 159–165.
13. Giulian D., Haverkamp L. J., Li J., Karshin W. L., Yu J., Tom D., Li X. and Kirkpatrick J. B. (1995) Senile plaques
stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int. 27, 119–137.
14. Goldgaber D., Harris H. W., Hla T., Maciag T., Donnelly R. J., Jacobsen J. S., Vitek M. P. and Gajdusek D. C. (1989)
Interleukin-1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelia cells. Proc. natn.
Acad. Sci. U.S.A. 86, 7606–7610.
15. Hanisch U.-K., Neuhaus J., Rowe W., Van Rossum D., Mo ̈ ller D., Kettenmann H. and Quirion R. (1997) Neurotoxic
consequences of central long-term administration of interleukin-2 in rats. Neuroscience 79, 799–818.
16. Ka ́lma ́n J., Engelhardt J. I., Le W. D., Xie W., Kovacs I., Ka ́sa P. and Appel S. H. (1997) Experimental
immune-mediated damage of septal cholinergic neurons. J. Neuroimmun. 77, 63–77.
17. Katsuura G., Gottschall P. E., Dahl R. R. and Airmura A. (1989) Interleukin-1â increases prostaglandin E in rat
2

astrocyte cultures: modulatory eVect of neuropeptides. Endocrinology 124, 3125–3127.
18. Lowry O. H., Rosenbrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with folin phenol reagent.
J. biol. Chem. 193, 265–275.
19. McGeer P. L., McGeer E. G., Suzuki J., Dolman C. E. and Nagai T. (1984) Aging, Alzheimer's disease and the
cholinergic system of the basal forebrain. Neurology 34, 741–745.
20. McGeer P. L., Akiyama H., Itagaki S. and McGeer E. G. (1989) Immune system response in Alzheimer's disease. Can.
J. neurol. Sci. 16, 516–527.
21. Morgan B. P. (1990) Complement: Clinical Aspects and Relevance to Disease, pp. 215–225. Academic, San Diego,
CA.
22. Mrak R. E., Sheng J. G. and GriYn W. S. T. (1995) Glial cytokines in Alzheimer's disease: review and pathogenic
implications. Human Path. 26, 816–823.
23. Perry V. H., Matyszak M. K. and Fearn S. (1993) Altered antigen expression of microglia in the aged rodent CNS.
Glia 7, 60–67.
24. Quan N., Sundar S. K. and Weiss J. M. (1994) Induction of interleukin-1 in various brain regions after peripheral and
central injections of lipopolysaccharide. J. Neuroimmun. 49, 125–134.
25. Radi R., Beckman J. S., Bush K. M. and Freeman B. A. (1991) Peroxynitrite oxidation of sulfhydryls. The cytotoxic
potential of superoxide and nitric oxide. J. biol. Chem. 266, 4244–4250.
26. Relton J. K. and Rothwell N. J. (1992) Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal
damage in the rat. Brain Res. Bull. 29, 243–246.
27. Rinne J. O., Paljarvi L. and Rinne K. (1987) Neuronal size and density in the nucleus basalis of Meynert in
Alzheimer's disease. J. neuronal Sci. 79, 67–76.
28. Rogers J., Cooper N., Webster S., Schultz J., McGeer P. L., Styren S. D., Civin W. H., Brachova L., Bradt B., Ward
P. and Lieberburg I. (1992) Complement activation by â-amyloid in Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A.
89, 10,016–10,020.
29. Rogers J., Kirby L. C., Hempelman S. R., Berry D. L., McGeer P. L., Kaszniak A. W., Zalinski J., Cofield M.,
Mansukhani L., Wilson P. and Kogan F. (1993) Clinical trials of indomethacin in Alzheimer's disease. Neurology 43,
1609–1611.
30. Rothwell N. J., Luheshi G. and Toulmond S. (1996) Cytokines and their receptors in the central nervous system:
physiology, pharmacology and pathology. Pharmac. Ther. 69, 85–95.
31. Sheng J. G., Ito K., Skinner R. D., Mrak R. E., Rovnaghi C. R., Van Eldik L. J. and GriYn S. T. (1996) In vivo and
in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer
pathogenesis. Neurobiol. Aging 17, 761–766.
32. Skaper S. D., Facci L. and Leon A. (1995) Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts
induces neuronal degeneration via the nitridergic pathway. J. Neurochem. 64, 266–276.
33. Swaab D. F., Hofman M. A., Lucassen P. J., Salehi A. and Uylings H. B. M. (1994) Neuronal atrophy, not cell death,
is the main hallmark of Alzheimer's disease. Neurobiol. Aging 15, 369–371.
34. Swierkosz T. A., Mitchell J. A., Warner T. D., Botting R. M. and Vane J. R. (1995) Co-induction of nitric oxide
synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br. J. Pharmac. 114, 1335–1342.
35. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A. and Katzman R. (1991)
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive
impairment. Ann. Neurol. 30, 572–580.
36. Van Antwerp D. J., Martin S. J., Kafri T., Green D. R. and Verman I. M. (1996) Suppression of TNF-Æ-induced
apoptosis by NF-ŔB. Science 274, 787–789.
37. Van der Zee C. E. E. M., Ross G. M., Riopelle R. J. and Hagg T. (1996) Survival of cholinergic forebrain neurons in
developing p75 deficient mice. Science 274, 1729–1732.
